What we're reading, July 5, 2016: South Carolina's Obamacare health insurance exchange is close to collapse; hepatitis C virus treatment restrictions are being slowly lifted; and a special feature on what foods are healthy.
South Carolina health officials warn that the state’s health insurance marketplace set up under the Affordable Care Act is close to collapse. In most of South Carolina, the marketplace is dominated by BlueCross BlueShield and choices will become even more limited as UnitedHealthcare prepares to leave, reported The Post and Courier. Insurers have been struggling to make money on the exchange, which has often-sick patients.
Curbs on hepatitis C virus treatments are slowly being lifted around the country. Kaiser Health News highlighted the state Medicaid programs that have expanded access in the last few months and other ways restrictive policies are going away. Private insurers that had taken their cues from states and were only providing the treatments for their sickest patients have begun reversing policies under threat of lawsuits. Anthem Blue Cross and Blue Shield plans in 14 states and UnitedHealthcare nationwide are 2 of the insurers that have extended hepatitis C treatments to patients who have not developed severe liver disease.
The New York Times’ blog The Upshot has a special feature on what foods are healthy. While the question seems simple enough, a poll of nutritionists and of the American public found a surprising diversity of opinion. Interestingly enough, the differences didn’t just appear between the 2 groups, but also among experts. So how healthy is a granola bar or hummus or sushi?
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More